scholarly journals User Experience of Brazilian Public Healthcare System. A case study on the accessibility of the information provided.

2019 ◽  
Vol 22 (sup1) ◽  
pp. 707-721
Author(s):  
Emilene Zitkus ◽  
Claudia Libanio
Keyword(s):  
Healthcare System ◽  
User Experience ◽  
Public Healthcare ◽  
Public Healthcare System ◽  
System A

Disparities in surgical management of endometrial cancers in a public healthcare system: A question of equity

2020 ◽  
Vol 159 (2) ◽  
pp. 387-393
Author(s):  
Limor Helpman ◽  
Gregory R. Pond ◽  
Lorraine Elit ◽  
Laura N. Anderson ◽  
Hsien Seow
Keyword(s):  
Healthcare System ◽  
Surgical Management ◽  
Public Healthcare ◽  
Public Healthcare System ◽  
System A ◽  
Endometrial Cancers

scholarly journals Spinal cord injury in the Moroccan healthcare system: A country case study

2021 ◽  
Vol 10 ◽  
pp. 62-65
Author(s):  
Abderrazak Hajjioui ◽  
Maryam Fourtassi ◽  
Saïd Boujraf
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Healthcare System ◽  
System A ◽  
Country Case Study ◽  
Cord Injury

Integrating a Pilot Newborn Screening for Spinal Muscular Atrophy Into the Australian Public Healthcare System

2021 ◽  
Author(s):  
Arlene M. D'Silva ◽  
Hugo Sampaio ◽  
Didu Sanduni Thamarasa Kariyawasam ◽  
David Mowat ◽  
Jacqui Russell ◽  
...  
Keyword(s):  
Spinal Muscular Atrophy ◽  
Newborn Screening ◽  
Healthcare System ◽  
Muscular Atrophy ◽  
Public Healthcare ◽  
Public Healthcare System

scholarly journals CRISPR, μια νέα τεχνολογία γενετικής παρέμβασης: Πρόταση αξιοποίησης σε ένα δημόσιο σύστημα υγείας

Bioethica ◽  
2020 ◽  
Vol 6 (2) ◽  
pp. 30
Author(s):  
Nikolaos Kolisis (Νικόλαος Κολίσης)
Keyword(s):  
Human Genome ◽  
Healthcare System ◽  
Public Healthcare ◽  
Public Healthcare System ◽  
Current Discussion ◽  
Potential Applications

The invention of CRISPR technology and its current and potential applications have been a subject of controversy among scientists, philosophers and legal theorists. After taking under consideration the current discussion concerning the use of CRISPR for editing human genome the article treats the question of a wider offer of CRISPR-based therapies from a Public Healthcare system and proposes method for a fair and financially sustainable way for adopting the new possibilities this new tool has to offer.

Sign in / Sign up

Export Citation Format

Share Document